Terms: = Ovarian cancer AND BCOR, ANOP2, 54880, ENSG00000183337, MAA2, MCOPS2, FLJ38041, KIAA1575, MGC131961, FLJ20285, MGC71031 AND Diagnosis
5 results:
1. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
2. Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
Gadducci A; Multinu F; De Vitis LA; Cosio S; Carinelli S; Aletti GD
Gynecol Oncol; 2023 Apr; 171():95-105. PubMed ID: 36842409
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and bcor in High-grade Endometrial Carcinomas.
Dyhdalo KS; Ababneh E; Lanigan C; Bowers K; Zhang S; McKenney JK; Joehlin-Price AS
Int J Gynecol Pathol; 2023 Sep; 42(5):443-450. PubMed ID: 36731037
[TBL] [Abstract] [Full Text] [Related]
4. ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases.
Shao Y; Liu Q; Shi H; Lu B
Diagn Pathol; 2020 Apr; 15(1):35. PubMed ID: 32290854
[TBL] [Abstract] [Full Text] [Related]
5. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
[TBL] [Abstract] [Full Text] [Related]